Current Report Filing (8-k)
May 23 2016 - 4:03PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): May 23, 2016 (May 20, 2016)
Neuralstem, Inc.
(Exact name of registrant as specified
in Charter)
Delaware
|
|
001-33672
|
|
52-2007292
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(Commission File No.)
|
|
(IRS Employee Identification No.)
|
20271 Goldenrod Lane, 2
nd
Floor, Germantown, Maryland 20876
(Address of Principal Executive Offices)
(301) 366-4960
(Issuer Telephone number)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
|
|
|
|
Item 2.05.
|
Costs Associated with Exit or Disposal Activities.
|
On May 20, 2016, Neuralstem, Inc.
(the “Company”), in order to better utilize the Company’s resources on the implementation of its refocused clinical
and corporate strategy, committed to a cost-reduction plan. This cost-reduction plan includes a reduction in force across all of
the Company’s departments. The Company expects to complete the reduction in force, and to substantially complete the
payment of any employee severance and benefits incurred as a result of such action by the end of the second quarter of 2016.
As a result of the reduction in force,
the Company estimates that it will incur aggregate expenses of approximately $750,000 consisting of (i) cash payments of $700,000
for severance payments, expenses related to the closing of facilities and contingencies, and (ii) charges of $50,000 related to
the vesting of options and extension of exercise periods of such options.
|
Item 7.01
|
Regulation FD Disclosure.
|
On May 19, 2016, we announced the reduction
in force in a press release. A copy of the press release is attached to this report as Exhibit 99.01.
The information contained in this Item
7.01 to this Current Report on Form 8-K and the exhibit attached hereto pertaining to this item shall not be deemed to be “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall such information or such exhibits be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference
in such a filing. The information set forth in the exhibits to this Form 8-K relating to this item 7.01 shall not be deemed an
admission as to the materiality of any information in this report that is required to be disclosed solely to satisfy the requirements
of Regulation FD.
|
Item 9.01
|
Financial Statements and Exhibits.
|
|
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.01
|
|
Press Release dated May 20, 2016
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto
duly authorized.
Date:
|
May 23, 2016
|
Neuralstem, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Richard Daly
|
|
|
|
By: Richard Daly
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
INDEX OF EXHIBITS
Exhibit
No.
|
|
Description
|
|
|
99.01
|
|
Press Release dated May 20, 2016
|
|
Neuralstem (NASDAQ:CUR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neuralstem (NASDAQ:CUR)
Historical Stock Chart
From Apr 2023 to Apr 2024